References
"Millan, M,J, et al,: J, Pharmacol, Exp, Therap,, 297, 876 (2001); Gobert, A, et al,: J, Pharmacol, Exp, Therap,, 305, 338 (2003); Bochkarev, V,K, et al,: Zh, Nevrol, Psikhiatr, Im, S,S, Korsakova, 105, 46 (2005);"
Application Notes
Piribedil is an antiparkisonian agent that acts as a dopamine agonist. Piribedil also displays a2-adrenergic antagonist properties. Piribedil has also been shown to counteract age-related memory impairment by improving memory and attention as well as increasing the velocity of psychomotor reactions and lability of nervous processes.